Cell Line : LB2518-MEL
Cellosaurus Index : CVCL_1366
Cellosaurus ID : LB2518-MEL
GDSC1 Name
, GDSC2 Name
: LB2518-MEL
CCLE Name
: LB2518MEL_SKIN
Cancer Type : skin
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| LB2518-MEL | (5Z)-7-Oxozeaenol | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | 5-Fluorouracil | GDSC1,GDSC2 | 0.0200 | 32.0000 |
|
| LB2518-MEL | 965-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | 993-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | A-443654 | GDSC1 | 0.0040 | 1.0240 |
|
| LB2518-MEL | A-770041 | GDSC1 | 0.0200 | 5.1200 |
|
| LB2518-MEL | A-83-01 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | ABT737 | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | ACY-1215 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | Afatinib | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| LB2518-MEL | Afuresertib | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | AGI-5198 | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | AGI-6780 | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| LB2518-MEL | AGK-2 | GDSC2 | 0.0040 | 4.0000 |
|
| LB2518-MEL | AICA Ribonucleotide | GDSC1 | 7.8125 | 2000.0000 |
|
| LB2518-MEL | AKT inhibitor VIII | GDSC1 | 0.0100 | 10.2400 |
|
| LB2518-MEL | Alectinib | GDSC1 | 0.0200 | 5.1200 |
|
| LB2518-MEL | Alisertib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Alpelisib | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | AMG-319 | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Amuvatinib | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | Apitolisib | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | AR-42 | GDSC1 | 0.0200 | 5.1200 |
|
| LB2518-MEL | Ara-G | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | ARRY-520 | GDSC1 | 0.0010 | 0.2560 |
|
| LB2518-MEL | AS601245 | GDSC1 | 0.0312 | 8.0000 |
|
| LB2518-MEL | AS605240 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | AST-1306 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | AT-7519 | GDSC1 | 0.0400 | 10.2400 |
|
| LB2518-MEL | AT13148 | GDSC2 | 0.0080 | 8.0000 |
|
| LB2518-MEL | AT7867 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | Avagacestat | GDSC1,GDSC2 | 0.0100 | 10.2400 |
|
| LB2518-MEL | Axitinib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| LB2518-MEL | AZ20 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | AZ6102 | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | AZ628 | GDSC1 | 0.0156 | 4.0000 |
|
| LB2518-MEL | AZ960 | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | AZD1208 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | AZD1332 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | AZD1480 | GDSC1 | 0.0098 | 2.5000 |
|
| LB2518-MEL | AZD2014 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | AZD3514 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | AZD3759 | GDSC2 | 0.0010 | 1.0000 |
|
| LB2518-MEL | AZD4547 | GDSC1,GDSC2 | 0.0039 | 10.0000 |
|
| LB2518-MEL | AZD4877 | GDSC1 | 0.0002 | 0.0390 |
|
| LB2518-MEL | AZD5363 | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | AZD5438 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | AZD5582 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | AZD6094 | GDSC1 | 0.0098 | 2.5000 |
|
| LB2518-MEL | AZD6482 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | AZD6738 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | AZD7762 | GDSC1,GDSC2 | 0.0010 | 10.0000 |
|
| LB2518-MEL | AZD7969 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | AZD8055 | GDSC1 | 0.0078 | 2.0000 |
|
| LB2518-MEL | AZD8186 | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| LB2518-MEL | AZD8835 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | AZD8931 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | BAM7 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | BAY ACCi | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | BAY AKT1 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | BAY-61-3606 | GDSC1 | 0.0312 | 8.0000 |
|
| LB2518-MEL | BAY-HDAC11_1 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | BAY-HDAC11_2 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | BAY-HDAC11_4 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | BAY-MPS-combo 2 (paclitaxel 1 uM) | GDSC1 | 0.0039 | 1.0000 |
|
| LB2518-MEL | BAY-MPS-combo-1 (paclitaxel 5 uM) | GDSC1 | 0.0039 | 1.0000 |
|
| LB2518-MEL | BAY-MPS1 | GDSC1 | 0.0117 | 3.0000 |
|
| LB2518-MEL | Belinostat | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | Bexarotene | GDSC1 | 0.0312 | 8.0000 |
|
| LB2518-MEL | BI-2536 | GDSC1,GDSC2 | 0.0005 | 0.5000 |
|
| LB2518-MEL | BIBF-1120 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | BIBR-1532 | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Bicalutamide | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| LB2518-MEL | BIX02189 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | Bleomycin | GDSC1 | 0.2500 | 64.0000 |
|
| LB2518-MEL | Bleomycin (10 uM) | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | Bleomycin (50 uM) | GDSC1 | 0.1953 | 50.0000 |
|
| LB2518-MEL | BMS-345541 | GDSC1,GDSC2 | 0.0100 | 16.0000 |
|
| LB2518-MEL | BMS-509744 | GDSC1 | 0.0400 | 10.2400 |
|
| LB2518-MEL | BMS-536924 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | BMS-754807 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Bortezomib | GDSC1,GDSC2 | 0.0000 | 0.0200 |
|
| LB2518-MEL | Bosutinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| LB2518-MEL | BPTES | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | Brivanib, BMS-540215 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | Bryostatin 1 | GDSC1 | 0.0000 | 0.0080 |
|
| LB2518-MEL | Buparlisib | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | BX-912 | GDSC1 | 0.0400 | 10.2400 |
|
| LB2518-MEL | BX795 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | C-75 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | Cabozantinib | GDSC1 | 0.0200 | 5.1200 |
|
| LB2518-MEL | Camptothecin | GDSC2 | 0.0001 | 0.1000 |
|
| LB2518-MEL | CAP-232, TT-232, TLN-232 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | Capivasertib | GDSC1 | 0.1172 | 30.0000 |
|
| LB2518-MEL | CAY10566 | GDSC1 | 0.0100 | 2.5600 |
|
| LB2518-MEL | CAY10603 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | CCT-018159 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | CCT007093 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | CCT245232 | GDSC1 | 0.0008 | 0.2000 |
|
| LB2518-MEL | CCT245467 | GDSC1 | 0.0008 | 0.2000 |
|
| LB2518-MEL | CD532 | GDSC1 | 0.0200 | 5.1200 |
|
| LB2518-MEL | Cediranib | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Cetuximab | GDSC1 | 0.2570 | 65.8000 |
|
| LB2518-MEL | CGP-082996 | GDSC1 | 0.0200 | 5.1200 |
|
| LB2518-MEL | CGP-60474 | GDSC1 | 0.0010 | 0.2560 |
|
| LB2518-MEL | CHIR-99021 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | CI-1033 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | CI-1040 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | Cisplatin | GDSC1 | 0.0117 | 10.0000 |
|
| LB2518-MEL | CMK | GDSC1 | 0.0156 | 4.0000 |
|
| LB2518-MEL | CP466722 | GDSC1 | 0.0625 | 16.0000 |
|
| LB2518-MEL | CP724714 | GDSC1 | 0.0400 | 10.2400 |
|
| LB2518-MEL | CPI-613 | GDSC1 | 1.0000 | 256.0000 |
|
| LB2518-MEL | Crizotinib | GDSC1,GDSC2 | 0.0040 | 8.0000 |
|
| LB2518-MEL | CRT0105446 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | CRT0105950 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | CRT0160829 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | CUDC-101 | GDSC1 | 0.0200 | 5.1200 |
|
| LB2518-MEL | CX-5461 | GDSC1 | 0.0400 | 10.2400 |
|
| LB2518-MEL | Cyclopamine | GDSC1 | 0.0625 | 16.0000 |
|
| LB2518-MEL | Cyclophosphamide | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Cytarabine | GDSC1 | 0.0078 | 2.0000 |
|
| LB2518-MEL | CZC24832 | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Dabrafenib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Dacinostat | GDSC1 | 0.0040 | 1.0240 |
|
| LB2518-MEL | Dactinomycin | GDSC2 | 0.0008 | 0.8000 |
|
| LB2518-MEL | Dactolisib | GDSC1,GDSC2 | 0.0003 | 0.2500 |
|
| LB2518-MEL | Daporinad | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| LB2518-MEL | Dasatinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| LB2518-MEL | Dinaciclib | GDSC2 | 0.0010 | 1.0000 |
|
| LB2518-MEL | DMOG | GDSC1 | 15.6250 | 4000.0000 |
|
| LB2518-MEL | Docetaxel | GDSC1,GDSC2 | 0.0000 | 0.0125 |
|
| LB2518-MEL | Doramapimod | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Doxorubicin | GDSC1 | 0.0040 | 5.0000 |
|
| LB2518-MEL | Dyrk1b_0191 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | eEF2K Inhibitor, A-484954 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | EHT-1864 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Elesclomol | GDSC1,GDSC2 | 0.0002 | 0.2000 |
|
| LB2518-MEL | Embelin | GDSC1 | 0.1250 | 32.0000 |
|
| LB2518-MEL | Entinostat | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Entospletinib | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Enzastaurin | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | EphB4_9721 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | Epirubicin | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Epothilone B | GDSC1 | 0.0001 | 0.0320 |
|
| LB2518-MEL | EPZ004777 | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | EPZ5676 | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Erlotinib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| LB2518-MEL | Etoposide | GDSC1 | 0.0625 | 16.0000 |
|
| LB2518-MEL | ETP-45835 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | Fedratinib | GDSC1 | 0.0400 | 10.2400 |
|
| LB2518-MEL | FEN1_3940 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | FGFR_0939 | GDSC1 | 0.0098 | 2.5000 |
|
| LB2518-MEL | FGFR_3831 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | FH535 | GDSC1 | 0.1250 | 32.0000 |
|
| LB2518-MEL | Flavopiridol | GDSC1 | 0.0100 | 2.5600 |
|
| LB2518-MEL | FMK | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | Foretinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | FR-180204 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | FS106 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | FS112 | GDSC1 | 0.0195 | 5.0000 |
|
| LB2518-MEL | FTI-277 | GDSC1 | 0.0040 | 1.0240 |
|
| LB2518-MEL | FTY-720 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | Fulvestrant | GDSC1,GDSC2 | 0.0010 | 10.0000 |
|
| LB2518-MEL | FY012 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | FY026 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | FY069 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | GDC0810 | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Gefitinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| LB2518-MEL | Gemcitabine | GDSC1,GDSC2 | 0.0002 | 10.0000 |
|
| LB2518-MEL | Genentech Cpd 10 | GDSC1 | 0.0400 | 10.2400 |
|
| LB2518-MEL | GNE-317 | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | GNF-2 | GDSC1 | 0.0050 | 1.2800 |
|
| LB2518-MEL | GSK-J4 | GDSC1 | 0.1172 | 30.0000 |
|
| LB2518-MEL | GSK1059615 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | GSK1070916 | GDSC1 | 0.0100 | 2.5600 |
|
| LB2518-MEL | GSK1904529A | GDSC1,GDSC2 | 0.0040 | 5.0000 |
|
| LB2518-MEL | GSK2578215A | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | GSK2606414 | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | GSK269962A | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| LB2518-MEL | GSK319347A | GDSC1 | 0.0195 | 5.0000 |
|
| LB2518-MEL | GSK343 | GDSC2 | 0.0010 | 1.0000 |
|
| LB2518-MEL | GSK429286A | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | GSK591 | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | GSK650394 | GDSC1 | 0.0625 | 16.0000 |
|
| LB2518-MEL | GSK690693 | GDSC1 | 0.0400 | 10.2400 |
|
| LB2518-MEL | GW-2580 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | GW441756 | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| LB2518-MEL | GW843682X | GDSC1 | 0.0010 | 0.2560 |
|
| LB2518-MEL | HG-5-113-01 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | HG-5-88-01 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | HG6-64-1 | GDSC1 | 0.0200 | 5.1200 |
|
| LB2518-MEL | I-BET-762 | GDSC1,GDSC2 | 0.0100 | 20.0000 |
|
| LB2518-MEL | I-BET151 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | I-BRD9 | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | I-CBP112 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | IAP_5620 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | IAP_7638 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | Ibrutinib | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | IC-87114 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | ICL1100013 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | Idelalisib | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | IGFR_3801 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | Imatinib | GDSC1 | 0.0078 | 2.0000 |
|
| LB2518-MEL | IMD-0354 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | IOX2 | GDSC1,GDSC2 | 0.0004 | 0.5000 |
|
| LB2518-MEL | IPA-3 | GDSC1 | 0.1250 | 32.0000 |
|
| LB2518-MEL | Ipatasertib | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Irinotecan | GDSC2 | 0.0050 | 5.0000 |
|
| LB2518-MEL | Ispinesib Mesylate | GDSC1 | 0.0005 | 0.1280 |
|
| LB2518-MEL | IWP-2 | GDSC2 | 0.0010 | 1.0000 |
|
| LB2518-MEL | JAK1_3715 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | JAK3_7406 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | JNJ38877605 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | JNK Inhibitor VIII | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | JNK-9L | GDSC1 | 0.0200 | 5.1200 |
|
| LB2518-MEL | JQ1 | GDSC1,GDSC2 | 0.0039 | 10.0000 |
|
| LB2518-MEL | JQ12 | GDSC1 | 0.0200 | 5.1200 |
|
| LB2518-MEL | JW-7-24-1 | GDSC1 | 0.0400 | 10.2400 |
|
| LB2518-MEL | JW-7-52-1 | GDSC1 | 0.0047 | 1.2000 |
|
| LB2518-MEL | kb NB 142-70 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | KIN001-042 | GDSC1 | 0.0400 | 10.2400 |
|
| LB2518-MEL | KIN001-236 | GDSC1 | 0.0400 | 10.2400 |
|
| LB2518-MEL | KIN001-244 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | KIN001-260 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | KIN001-266 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | KIN001-270 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | Kobe2602 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | KRAS (G12C) Inhibitor-12 | GDSC2 | 0.0200 | 20.0000 |
|
| LB2518-MEL | KU-55933 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | KU-60019 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | Lapatinib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| LB2518-MEL | LCL161 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | LDN-193189 | GDSC1 | 0.0400 | 10.2400 |
|
| LB2518-MEL | Leflunomide | GDSC2 | 0.1001 | 100.0000 |
|
| LB2518-MEL | Lenalidomide | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Lestaurtinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| LB2518-MEL | LFM-A13 | GDSC1 | 0.0625 | 16.0000 |
|
| LB2518-MEL | LGK974 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | LIMK1 inhibitor BMS4 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | Linifanib | GDSC1 | 0.0040 | 1.0240 |
|
| LB2518-MEL | Linsitinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | LJI308 | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Luminespib | GDSC1,GDSC2 | 0.0003 | 0.2560 |
|
| LB2518-MEL | LY2109761 | GDSC2 | 0.0050 | 5.0000 |
|
| LB2518-MEL | Masitinib | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | MCT1_6447 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | MCT4_1422 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | MetAP2 Inhibitor, A832234 | GDSC1 | 0.0100 | 2.5600 |
|
| LB2518-MEL | Methotrexate | GDSC1,GDSC2 | 0.0008 | 1.0000 |
|
| LB2518-MEL | MG-132 | GDSC1,GDSC2 | 0.0039 | 4.0000 |
|
| LB2518-MEL | Midostaurin | GDSC1 | 0.0020 | 0.5120 |
|
| LB2518-MEL | MIM1 | GDSC1 | 0.1562 | 40.0000 |
|
| LB2518-MEL | MIRA-1 | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Mirin | GDSC1,GDSC2 | 0.1001 | 100.0000 |
|
| LB2518-MEL | Mitomycin-C | GDSC1 | 0.0625 | 16.0000 |
|
| LB2518-MEL | MK-1775 | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | MK-2206 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | MK-8776 | GDSC2 | 0.0050 | 5.0000 |
|
| LB2518-MEL | ML323 | GDSC2 | 0.0200 | 20.0000 |
|
| LB2518-MEL | MN-64 | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Motesanib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| LB2518-MEL | MPS-1-IN-1 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | N22899-6-C1 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | N23918-95-7 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | N24798-49-A1 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | Navitoclax | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| LB2518-MEL | NG-25 | GDSC1 | 0.0400 | 10.2400 |
|
| LB2518-MEL | Nilotinib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| LB2518-MEL | Niraparib | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | NPK76-II-72-1 | GDSC1 | 0.0400 | 10.2400 |
|
| LB2518-MEL | NSC-207895 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | NSC-87877 | GDSC1 | 0.0625 | 16.0000 |
|
| LB2518-MEL | NSC319726 | GDSC1 | 0.0010 | 0.2560 |
|
| LB2518-MEL | NU7441 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| LB2518-MEL | Nutlin-3a | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | NVP-ADW742 | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | NVP-BHG712 | GDSC1 | 0.0400 | 10.2400 |
|
| LB2518-MEL | NVP-TAE684 | GDSC1 | 0.0078 | 2.0000 |
|
| LB2518-MEL | Obatoclax Mesylate | GDSC1 | 0.0625 | 16.0000 |
|
| LB2518-MEL | OF-1 | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Olaparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Omipalisib | GDSC1 | 0.0005 | 0.1280 |
|
| LB2518-MEL | OSI-027 | GDSC1,GDSC2 | 0.0100 | 20.0000 |
|
| LB2518-MEL | OSI-930 | GDSC1 | 0.0400 | 10.2400 |
|
| LB2518-MEL | Osimertinib | GDSC2 | 0.0010 | 1.0000 |
|
| LB2518-MEL | OSU-03012 | GDSC1 | 0.0625 | 16.0000 |
|
| LB2518-MEL | OTX015 | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Oxaliplatin | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | P22077 | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | PAC-1 | GDSC1 | 0.0100 | 2.5600 |
|
| LB2518-MEL | Paclitaxel | GDSC1,GDSC2 | 0.0001 | 0.1024 |
|
| LB2518-MEL | Palbociclib | GDSC1,GDSC2 | 0.0040 | 4.0000 |
|
| LB2518-MEL | Panobinostat | GDSC1 | 0.0040 | 1.0240 |
|
| LB2518-MEL | PARP_0108 | GDSC1 | 0.0098 | 2.5000 |
|
| LB2518-MEL | PARP_9482 | GDSC1 | 0.0098 | 2.5000 |
|
| LB2518-MEL | PARP_9495 | GDSC1 | 0.0098 | 2.5000 |
|
| LB2518-MEL | Parthenolide | GDSC1 | 0.0195 | 5.0000 |
|
| LB2518-MEL | Pazopanib | GDSC1 | 0.0312 | 8.0000 |
|
| LB2518-MEL | PCI-34051 | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | PD0325901 | GDSC1,GDSC2 | 0.0010 | 2.5000 |
|
| LB2518-MEL | PD173074 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| LB2518-MEL | Pelitinib | GDSC1 | 0.0098 | 2.5000 |
|
| LB2518-MEL | Pemetrexed | GDSC1 | 0.0100 | 2.5600 |
|
| LB2518-MEL | Pevonedistat | GDSC1,GDSC2 | 0.0039 | 10.0000 |
|
| LB2518-MEL | PF-00299804 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | PF-4708671 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | PF-562271 | GDSC1 | 0.0100 | 2.5600 |
|
| LB2518-MEL | PFI-1 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | PFI3 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | PHA-665752 | GDSC1 | 0.0078 | 2.0000 |
|
| LB2518-MEL | PHA-793887 | GDSC1 | 0.0400 | 10.2400 |
|
| LB2518-MEL | Phenformin | GDSC1 | 15.6250 | 4000.0000 |
|
| LB2518-MEL | PI-103 | GDSC1 | 0.0400 | 10.2400 |
|
| LB2518-MEL | PI3Ka_4409 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | Picolinici-acid | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Pictilisib | GDSC1,GDSC2 | 0.0040 | 4.0000 |
|
| LB2518-MEL | PIK-93 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | Pilaralisib | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | Piperlongumine | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | PLK_6522 | GDSC1 | 0.0024 | 0.6250 |
|
| LB2518-MEL | PLX-4720 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Ponatinib | GDSC1 | 0.0020 | 0.5120 |
|
| LB2518-MEL | PRIMA-1MET | GDSC2 | 0.0300 | 30.0000 |
|
| LB2518-MEL | PRT062607 | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Pyridostatin | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Pyrimethamine | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | QL-VIII-58 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | QL-X-138 | GDSC1 | 0.0400 | 10.2400 |
|
| LB2518-MEL | QL-XI-92 | GDSC1 | 0.0400 | 10.2400 |
|
| LB2518-MEL | QL-XII-47 | GDSC1 | 0.0400 | 10.2400 |
|
| LB2518-MEL | QL-XII-61 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | QS11 | GDSC1 | 0.0400 | 10.2400 |
|
| LB2518-MEL | Quizartinib | GDSC1 | 0.0040 | 1.0240 |
|
| LB2518-MEL | RAF_9304 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | Rapamycin | GDSC1,GDSC2 | 0.0001 | 0.1000 |
|
| LB2518-MEL | Refametinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Ribociclib | GDSC2 | 0.0020 | 2.0000 |
|
| LB2518-MEL | RO-3306 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | rTRAIL | GDSC1 | 0.0004 | 0.1000 |
|
| LB2518-MEL | RU-SKI 43 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | Rucaparib | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| LB2518-MEL | Ruxolitinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | RVX-208 | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | S-Trityl-L-cysteine | GDSC1 | 0.0200 | 5.1200 |
|
| LB2518-MEL | Sabutoclax | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Salubrinal | GDSC1 | 0.0625 | 16.0000 |
|
| LB2518-MEL | Sapitinib | GDSC2 | 0.0050 | 5.0000 |
|
| LB2518-MEL | Saracatinib | GDSC1 | 0.0078 | 2.0000 |
|
| LB2518-MEL | Savolitinib | GDSC2 | 0.0010 | 1.0000 |
|
| LB2518-MEL | SB216763 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | SB505124 | GDSC1,GDSC2 | 0.0100 | 20.0000 |
|
| LB2518-MEL | SB52334 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | SB590885 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| LB2518-MEL | SCH772984 | GDSC2 | 0.0050 | 5.0000 |
|
| LB2518-MEL | Seliciclib | GDSC1 | 0.0625 | 16.0000 |
|
| LB2518-MEL | Selisistat | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | Selumetinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Sepantronium bromide | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Serdemetan | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | SGC0946 | GDSC1,GDSC2 | 0.0005 | 0.5000 |
|
| LB2518-MEL | Shikonin | GDSC1 | 0.0625 | 16.0000 |
|
| LB2518-MEL | SL0101 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | SN-38 | GDSC1,GDSC2 | 0.0002 | 10.0000 |
|
| LB2518-MEL | SNX-2112 | GDSC1 | 0.0100 | 2.5600 |
|
| LB2518-MEL | Sorafenib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Sphingosine Kinase 1 Inhibitor II | GDSC1 | 0.0100 | 2.5600 |
|
| LB2518-MEL | Staurosporine | GDSC2 | 0.0078 | 2.0000 |
|
| LB2518-MEL | STF-62247 | GDSC1 | 0.0400 | 10.2400 |
|
| LB2518-MEL | SU11274 | GDSC1 | 0.0400 | 10.2400 |
|
| LB2518-MEL | Sunitinib | GDSC1 | 0.0312 | 8.0000 |
|
| LB2518-MEL | T0901317 | GDSC1 | 0.0400 | 10.2400 |
|
| LB2518-MEL | TAK-715 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | Talazoparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Tamoxifen | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Tanespimycin | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| LB2518-MEL | TANK_1366 | GDSC1 | 0.0098 | 2.5000 |
|
| LB2518-MEL | Taselisib | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Telomerase Inhibitor IX | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Temozolomide | GDSC1,GDSC2 | 0.0300 | 30.0000 |
|
| LB2518-MEL | Temsirolimus | GDSC1,GDSC2 | 0.0008 | 1.0000 |
|
| LB2518-MEL | Tenovin-6 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | TGX221 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | Thapsigargin | GDSC1 | 0.0020 | 0.5120 |
|
| LB2518-MEL | THZ-2-102-1 | GDSC1 | 0.0098 | 2.5000 |
|
| LB2518-MEL | THZ-2-49 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | Tipifarnib | GDSC1 | 0.0625 | 16.0000 |
|
| LB2518-MEL | Tivozanib | GDSC1 | 0.0005 | 0.1280 |
|
| LB2518-MEL | TL-1-85 | GDSC1 | 0.0400 | 10.2400 |
|
| LB2518-MEL | TL-2-105 | GDSC1 | 0.0400 | 10.2400 |
|
| LB2518-MEL | Torin 2 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | Tozasertib | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| LB2518-MEL | TPCA-1 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | Trametinib | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| LB2518-MEL | Tretinoin | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Trichostatin A | GDSC1 | 0.0040 | 1.0240 |
|
| LB2518-MEL | TTK_3146 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | Tubastatin A | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | TW 37 | GDSC1 | 0.0195 | 5.0000 |
|
| LB2518-MEL | TWS119 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | Ulixertinib | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | UNC0638 | GDSC1 | 0.0781 | 40.0000 |
|
| LB2518-MEL | UNC0642 | GDSC1 | 0.0020 | 0.5000 |
|
| LB2518-MEL | UNC1215 | GDSC1 | 0.0039 | 1.0000 |
|
| LB2518-MEL | Uprosertib | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | VE-822 | GDSC2 | 0.0050 | 5.0000 |
|
| LB2518-MEL | VE821 | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Veliparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Venetoclax | GDSC2 | 0.0010 | 1.0000 |
|
| LB2518-MEL | Venotoclax | GDSC1 | 0.0010 | 0.2560 |
|
| LB2518-MEL | Vinblastine | GDSC1 | 0.0004 | 0.1000 |
|
| LB2518-MEL | Vinorelbine | GDSC1,GDSC2 | 0.0001 | 0.1000 |
|
| LB2518-MEL | Vismodegib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | VNLG-124 | GDSC1 | 0.0200 | 5.1200 |
|
| LB2518-MEL | Vorinostat | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Voxtalisib | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | VX-11e | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | VX-702 | GDSC1 | 0.0078 | 2.0000 |
|
| LB2518-MEL | Wee1 Inhibitor | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| LB2518-MEL | WEHI-539 | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | WH-4-023 | GDSC1 | 0.0200 | 5.1200 |
|
| LB2518-MEL | WHI-P97 | GDSC1 | 0.0400 | 10.2400 |
|
| LB2518-MEL | WIKI4 | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | Wnt-C59 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | WYE-125132 | GDSC1 | 0.0400 | 10.2400 |
|
| LB2518-MEL | WZ-1-84 | GDSC1 | 0.0400 | 10.2400 |
|
| LB2518-MEL | WZ3105 | GDSC1 | 0.0050 | 1.2800 |
|
| LB2518-MEL | WZ4003 | GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | XAV939 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| LB2518-MEL | XMD11-85h | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | XMD13-2 | GDSC1 | 0.0400 | 10.2400 |
|
| LB2518-MEL | XMD14-99 | GDSC1 | 0.0400 | 10.2400 |
|
| LB2518-MEL | XMD15-27 | GDSC1 | 0.0400 | 10.2400 |
|
| LB2518-MEL | XMD8-85 | GDSC1 | 0.0312 | 8.0000 |
|
| LB2518-MEL | XMD8-92 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | Y-39983 | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | YK-4-279 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | YM201636 | GDSC1 | 0.0200 | 5.1200 |
|
| LB2518-MEL | Z-LLNle-CHO | GDSC1 | 0.0100 | 2.5600 |
|
| LB2518-MEL | ZG-10 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | Zibotentan | GDSC1 | 0.0781 | 20.0000 |
|
| LB2518-MEL | ZL049 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | ZL109 | GDSC1 | 0.0391 | 10.0000 |
|
| LB2518-MEL | ZM447439 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB2518-MEL | ZSTK474 | GDSC1 | 0.0200 | 5.1200 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC